CMI: Obesity, diabetes, and hypertension in hospitalized patients with Coronavirus 2019 are related to severe outcomes

Purpose: A preliminary study of COVID-19 patients showed that obesity, diabetes, and hypertension are associated with severe outcomes
.

Later, some authors pointed out that the risk may vary depending on age, gender, comorbidities, and medical history

Preliminary studies on COVID-19 patients indicate that obesity, diabetes, and hypertension are associated with severe outcomes

Results: 134,209 hospitalized adult COVID-19 patients were included, among which hypertension patients accounted for half (N=66,613, 49.
6%), diabetes patients accounted for a quarter (N=32,209, 24.
0%) or obese patients (N=32,070, 23.
9%)
.

In this cohort, 13,596 hospitalized patients required IMV, and 19,969 patients died

Figure 1 Mortality, mechanical ventilation and Charlson scores of obesity in different age groups

Figure 1 Mortality, mechanical ventilation and Charlson scores of obesity in different age groups

Figure 2 Age, gender, mechanical ventilation, mortality, and Charlson score

Figure 2 Age, gender, mechanical ventilation, mortality, and Charlson score

Figure 3 Mechanical ventilation, mortality and Charlson score

Figure 3 Mechanical ventilation, mortality and Charlson score

Figure 4 Mechanical ventilation, Charlson's index, and hypertension mortality by age

Figure 4 Mechanical ventilation, Charlson's index, and hypertension mortality by age

Conclusion: Among the 134,209 COVID-19 hospitalized patients, obese and diabetic patients have a higher mortality rate
.

For hospitalized patients with obesity, diabetes, and hypertension, IMV is even more necessary

Among the 134,209 COVID-19 hospitalized patients, obese and diabetic patients have a higher mortality rate

Bailly L, Fabre R, Courjon J, et al.

Obesity, diabetes, hypertension and severe outcomes among inpatients with COVID-19: a nationwide study in this message